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Abstract The yeast ADE3(1-333) gene which encodes a trun- 
cated protein containing the N-terminal 5,10-methylene-tetrahy- 
drofolate (THF) dehydrogenase (D)15,10-methenyI-THF cy- 
clohydrolase (C) domain of cytoplasmic trifunctional C1-THF 
synthase is able to complement all the phenotypes associated with 
ade3 mutations in vivo. However, expression of the ADE3(1-333) 
gene in an ade3 strain does not retain any D activity in vitro. 
Expression in a yeast ade3 strain of the ADE3(1-333) fused to 
the Escherichia coli lacZ gene or to the yeast SER2 gene allows 
detection of D and C activities in vitro. These results indicate that 
the N-terminal DIC domain of C1-THF synthase requires the 
C-terminal 10-formyI-THF synthetase domain for stable cata- 
lytic activity in vitro. 
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1. Introduction 
The one-carbon derivatives of tetrahydrofolate (THF) serve 
as doners of one-carbon units in a variety of biosynthetic reac- 
tions involving purine bases (inosinic acid), pyrimidines (thy- 
mine), amino acids (methionine, serine, glycine), vitamins (pan- 
tothenic acid), and the initiation of protein synthesis in bacteria 
and organelles. The principal source of the one-carbon metab- 
olite is 5,10-methylene-THF normally derived from glucose via 
glycine [1], although it is also formed in a non-enzymic reaction 
by condensation of formaldehyde with THF. 
An enzymatic activity resulting in the formation of 10- 
formyl-THF in the presence of formate, THF and Mg-ATP was 
found in almost all cells examined, including those of bacteria, 
plants, yeasts and animals [1]. The only exception reported to 
date, however, is the absence of the enzyme from Escherichia 
coli and other enteric bacteria [2,3]. However, yeast [4] and 
vertebrate species [1] unlike prokaryotes, contain enzymes that 
are trifunctional. They possess in addition to the 10-formyl- 
THF synthetase (S) (EC 6.3.4.3), 5,10-methenyl-THF cyclohy- 
drolase (C) (EC 3.5.4.9) and 5,10-methylene-THF dehydroge- 
nase (D) (EC 1.5.1.5) activities. The trifunctional enzyme was 
named C1-THF synthase. D catalyzes the oxidation of 5,10- 
methylene-THF to 5,10-methenyl-THF and C catalyzes the 
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hydrolysis of 5,10-methenyl-THF to 10-formyl-THF. D and C 
occur as monofunctional or bifunctional proteins in prokaryo- 
tes. The monofunctional forms are found in Clostridium cylin- 
drosporum [5] and the bifunctional form is found in C. ther- 
moaceticum and E. coli [6,7]. 
The genes yielding the trifunctional enzymes have been 
cloned and sequenced from yeast cytoplasm (ADE3) [8] and 
mitochondria (MIS1) [9], and several other eukaryotic sources 
[10,11]. Comparison of the primary structures of the C1-THF 
synthases, deduced from the nucleotide sequences, reveals ex- 
tensive homology among the proteins. The C1-THF synthases 
are composed of two identical polypeptides. Proteolysis exper- 
iments with mammalian C1-THF synthases have shown that 
the protein can be separated into two functional domains: the 
N-terminal domain containing the D/C activities and the C- 
terminal domain containing the S activity, respectively [12,13]. 
Hum and MacKenzie have demonstrated that both domains of 
human C1-THF synthase form active enzymes and fold inde- 
pendently in E. coli [14]. In contrast, treatment of the yeast 
cytoplasmic C1-THF synthase with trypsin resulted in the 
decay of the D/C activities of the N-terminal domain, but the 
S activity of the C-terminal domain was retained [4]. 
In this report, we have examined the C I-THF synthase activ- 
ities in an ade3 deletion strain transformed with a plasmid 
carrying the ADE3(1-333) gene [15] (B and C, Fig. 1) coding for 
a truncated protein retaining the D/C domain but not the S 
domain of C1-THF synthase. Additional constructions were 
made in which the E. coli lacZ and the yeast SER2 gene re- 
placed the S portion of the ADE3 gene by fusing the E. coli lacZ 
gene to ADE3(I-333) and the SER2 gene to ADE3(1-666), re- 
spectively (D and E, Fig. 1). 
2. Materials and methods 
2.1. Strains and media 
The Saccharomyces revisiae strains used were GT48 (MATa ade3- 
130 serl-171 ura3-52), $40 (MATa ade3-130 misl-5 serl-171 ura3-52), 
and CBY4 (MATa ade3-65 serl-171 ura3-52 trpl leu2 his3 his4). The 
ade3-130 and ade3-65 alleles are ade3 deletion and D-deficient muta- 
tions, respectively [16,17]. The misl-5 allele is a misl disruption muta- 
tion with ura3-. Strain $40 carrying the misl-5 was isolated as a ura3 
strain able to grow on 5-fluoroorotic acid medium from the 
misl:: URA3 disruption mutant, which was constructed in strain 
GT48 through the gene replacement with plasmid pKS23 linearized 
with EcoRI and SalI [18]. SD medium is 0.17% yeast nitrogen base/0.5% 
ammonium sulfate/2% glucose and was supplemented with the follow- 
ing nutrients where indicated (final concentration in mg/l): adenine, 20; 
histidine, 20; serine, 400; uracil, 20; leucine, 30; tryptophan, 20; glycine, 
20; and formate, 1,000. Yeast transformations were performed by treat- 
ment with lithium acetate [19]. E. coli DH5~ was used to propagate 
plasmids. 
All rights reserved. 
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2.2. Plasmids 
Plasmids pJS8A and pJS8C are derivatives of centrometric plasmid 
YCp50 and episomal multicopy plasmid YEp24, respectively, and both 
carry the URA3 and ADE3 genes [15]. Plasmid pJS8A-A, containing 
the URA3 and ADE3(1-333) genes, is a derivative of YCp50 [15]. It was 
used to construct plasmid pBJL1 carrying the URA3 and the ADE3(1- 
333)-laeZ fusion gene. The ADE3(1-333) lacZ fusion gene was created 
by inserting a 6.8-kb BamHI fragment containing E. coli lacZ gene of 
pMC931 [20] into the HindIII site of the modified pJS8A-A, through 
the use of synthetic linkers and blunt-end ligation. This fusion gene 
consisted of the ADE3(1-333) fused to the lacZ gene with its first 7 
codons removed (Fig. 1D). Multicopy plasmid pJS54 carrying the 
ADE3(I-666)-SER2 fusion gene was constructed by removing the 4.1- 
kb Kpnl fragment from the multicopy plasmid pJS8C to yield the 
ADE3(l-666) fused to the SER2 gene (Song, J.M., Cheung, E. and 
Rabinowitz, J.C., GenBank/EMBL database with the accession um- 
ber U36473). The removal of the 4.1-kb KpnI fragment including the 
last 281 codons of tfie ADE3 and the first 40 codons of the SER2 from 
pJS8C created the ADE3(1-666)-SER2 fusion gene (Fig. 1E). The mul- 
ticopy plasmid pJS50 carrying the ADE3(1-333) gene was constructed 
by removing the 1.5-kb HindIII fragment in the S domain of the ADE3 
gene of multicopy plasmid YEpADE3 [8]. Plasmid pKS23 is a deriva- 
tive of pUC4 and carries a misl :: URA3 allele created by replacing the 
56-bp XhoI-SphI fragment at the 5'-end of MISl-coding sequence with 
a 1.l-kb fragment containing the URA3 gene [9]. 
2.3. Determination fgrowth rate 
Cultures were grown in 125 ml flasks at 30°C in a shaking water bath. 
Yeast cells carrying the URA3-bearing plasmids were grown in SD 
supplemented with adenine, histidine and serine. Growth rates of all 
strains were determined in SD medium supplemented with the indicated 
nutrients. Cells grown to an 00600 of 1 were harvested and washed in 
SD. Cells were then resuspended in SD and used to inoculate SD 
supplemented with the appropriate nutrients. Growth was monitored 
by measuring the 006o o . 
2.4. Enzyme assays 
Yeast cells carrying plasmids were grown in SD supplemented with 
appropriate nutrients to an OD6oo f 1, and harvested by centrifugation 
at 4°C. The cell pellets were resuspended in 2 volumes of buffer contain- 
ing 50 mM Tris-HCl, pH 7.5, 10 mM KC1, 10 mM 2-mercaptoethanol, 
and were disrupted with glass beads. Protease inhibitors, when used 
alone or in combination, were added to the buffer just before disrupting 
the cells with glass beads. PMSF, phenanthroline and benzamidine 
were added to final concentrations of 1 raM, 5 pM and 10/2M, respec- 
tively. Pepstatin A, leupeptin, chymostatin, aprotinin and antipain were 
added to a final concentration of 0.5/2g/ml. The lysates were then 
centrifuged at 25,000 × g for 30 min. The supernatant fractions were 
used for enzyme and protein assays. The S and D activities were assayed 
as previously described [16]. The activities are expressed in milli-units 
(nmols of 5,10-methenyl-THF formed or hydrolyzed/min) based on 
e = 24,900 M-~.cm ~ for 5,10-methenyl-THF. The C activity was meas- 
ured at room temperature asdescribed [21]. 1 milli-unit is equivalent 
to the formation of 1 nmol of product/min. Quantitative fl-galactosi- 
dase (fl-Gal) assays were carried out as described [22]. The fl-Gal activ- 
ity is expressed in units (nmols of 2-Nitrophenyl-fl-D-galactopyranosid 
hydrolyzed/min). Protein concentrations were determined by the dye- 
binding assay of Bradford [23] with bovine serum albumin as a stand- 
ard. 
3. Results and discussion 
3.1. Effect of expression of the ADE3(1-333) gene in ade3 
strains 
It has previously been shown that the plasmid-born N-termi- 
Plasmid 
Carried 
ADE3 
allele 
Encoded 
Ade3 
polypeptide 
pJS8A/ A ADE3 
pJS8C 
1 200 400 600 800 946aa 
I I I I I I 
1 304 320 946 
1 333-1 aa-stop 
B pJS8A-A ADE3(1-333) D/C l 
1 
c .JSSO AoE  I-333  I D/c 
1 
D pBJL1 ADE3(1-333)-IacZ I D/C 
1 
ADE3(1-666)-SER2 E pJS54 
333-21 aa-stop 
333-1016aa-stop 
lilllllllllllllllllllllll HPllllllllllllllllllhflllllllllllllllll 
666-269aa-stop 
Fig. 1. Ade3 polypeptides encoded by ADE3 alleles. Based on the homology to the amino acid sequences of procaryotic ounterparts, Ade3 
polypeptide is composed of a 304 amino acid N-terminal D/C domain (open box), a 627 amino acid C-terminal S domain (stippled box), and a 15 
amino acid interdomain (black box). The C-terminal regions of truncated proteins are deduced from the nucleotide sequences. The number of the 
created amino acid insertions (hatched box) is indicated before 'stop' for the termination codon. The fusion proteins contain fl-galactosidase (Gal) 
with the first 7 amino acids removed (vertically hatched box) and phosphoserine phosphatase (Pho) with the removed first 40 amino acids (horizontally 
hatched box). 
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Table 1 
Phenotypes of ade3 misl strain $40 with plasmids carrying different ADE3 alleles 
231 
Plasmid Carried ADE3 allele Growth rate (doubling time) Enzyme activity ~
+ Adenine - Adenine D C S fl-Gal 
h mU/mg U/mg 
YCp50 None (vector) 2.2 b 0.2 0 0 0 
pJS8A ADE3 2.2 2.2 18 42 151 0 
pJS8A-A ADE3(I-333) 2.1 2.1 0 3.8 0 0 
pB JL1  ADE3(I-333)-lacZ 2.2 2.2 8.2 14.5 0 493 
a The value below 1 mU/mg for the D activity could be an artifact of the assay method, since the boiled lysates ometimes show values below 1 mU/mg. 
b_, No sign of growth by 3 days. 
nal portion of the ADE3 gene, ADE3(1-333), coding for a 
truncated protein retaining the D/C domain but not the S do- 
main, is sufficient for complementation f the adenine require- 
ment associated with an amber mutation ade3-26 [15]. We have 
now determined the effect of expression of the ADE3(1-333) 
gene on the phenotypes associated with ade3 mutations in other 
ade3 strains. First, its effect on the adenine requirement associ- 
ated with the ade3 mutation was examined in the ade3 deletion 
strain GT48. The GT48 strain transformed with plasmid 
pJS8A-A (Fig. 1B) carrying the ADE3(1-333) gene does not 
require adenine for growth. Second, an alternative phenotypic 
assay for catalytic function of the ADE3 C1-THF synthase not 
related to the adenine requirement is based on the inability of 
ade3 serl mutants to satisfy their serine requirement by utilizing 
glycine and formate to synthesize serine [24]. To test this cata- 
lytic ability, plasmid pJS8A-A was transformed into ade3-65 
serl strain CBY4. The ade3-65 mutant exhibited wild-type lev- 
els of S and C activities but little D activity above that derived 
from the mitochondrial C1-THF synthase and little growth on 
+Glycine/formate [17]. The CBY4 transformant with the plas- 
mid pJS8A-A which is able to complement the adenine require- 
ment in ade3 deletion strain GT48, grows well on +Glycine/ 
formate like the one with plasmid pJS8A carrying the ADE3 
gene. These results indicate that the ADE3(1-333) gene encod- 
ing a truncated protein containing the N-terminal D/C domain 
is able to complement all the phenotypes associated with ade3 
mutations in vivo. Then, we analyzed crude extracts of the 
GT48 strain transformed with the plasmid pJS8A-A for the 
enzymatic activities. The specific activity of D in the transfor- 
mant with the plasmid pJS8A-A was 6.4 mU/mg, while that of 
the transformants with the plasmids YCp50 and pJS8A were 
5.2 and 26.1 mU/mg, respectively. These results indicate that 
the transformant with the plasmid pJS8A-A showed little D 
activity above that derived from the mitochondrial C1-THF 
synthase. In order to determine the enzymatic activities of cyto- 
plasmic C1-THF synthase, we have disrupted the MIS1 gene 
in the ade3 deletion strain GT48. The $40 strain was then 
transformed with the plasmid pJS8A-A. The transformant does 
not require adenine for growth. Enzyme assays how that it has 
no D activity but a little C activity (Table 1). 
One explanation for the lack of demonstrable D activity of 
the $40 strain transformed with the plasmid pJS8A-A is that 
its D activity is barely detected in vitro, since its C activity is 
also lower than the one of the $40 strain transformed with the 
plasmid pJS8A. To investigate this possibility, a multicopy 
plasmid pJS50 carrying the ADE3(1-333) gene was constructed. 
Results of enzyme assays in crude extracts prepared from the 
$40 strain transformed with the plasmid pJS50 are shown in 
Table 2. The transformant with the multicopy plasmid pJS50 
exhibits the 11-fold higher C activity than the one with the low 
copy plasmid pJS8A-A. However, it still does not have any D 
activity (Tables 1 and 2). 
Another possibility for the inability to detect D activity is 
that the D activity of the transformant is destroyed by proteases 
during the preparation of crude extracts, since we do not use 
any protease inhibitor in the preparation of crude extracts for 
C1-THF synthase. We therefore tested eight commonly used 
protease inhibitors alone or in combination. However, none of 
the treated extracts howed much D activity. We also have been 
unable to detect any D activity in extracts prepared at 0°C and 
assayed as quickly as possible (~30 min after cell breakage). 
In summary, the N-terminal D/C domain of C1-THF syn- 
thase encoded by the ADE3(1-333) gene is active in vivo by 
complementing all the phenotypes associated with ade3 muta- 
tions. However, extracts of these cells have no detectable D
activity in vitro. Addition of protease inhibitors during prepa- 
ration of cell extracts does not have any effect on our inability 
to detect D activity in extracts. These results suggest hat the 
D/C activities of the N-terminal domain of C1-THF synthase 
may be affected by the C-terminal domain in vitro. 
3.2. Effect of expression of fusion genes in ade3 strain 
To examine the effect of the C-terminal domain of the C 1- 
THF synthase on the D/C activity of its N-terminal domain, we 
have constructed the ADE3(1-333) encoding a truncated pro- 
tein containing the N-terminal D/C domain of C1-THF syn- 
thase fused to E. coli laeZ encoding fl-galactosidase. The con- 
structed low copy plasmid pBJL1 carrying the fusion gene 
ADE3(1-333)-lacZ was then transformed into ade3 misl strain 
$40. The transformant does not require adenine for growth, 
suggesting that the fusion gene is active in vivo. Results of 
enzyme assay in crude extracts prepared from the transformant 
are shown in Table 1. Indeed, the transformant with the plas- 
mid pBJL1 carrying the ADE3(1-333)-lacZ fusion gene re- 
Table 2 
Enzymatic activities of overexpressed A e3 proteins in ade3 misl strain 
$40 
Plasmid Carried ADE3 allele Enzymatic activity a (mU/mg) 
D C S 
YEp24 Vector 0.1 0 0 
pJS8C ADE3 184 454 1686 
pJS50 ADE3(I-333) 0.3 43 0 
pJS54 ADE3(1-666) SER2 5.1 26 0 
See the footnote of Table 1. 
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Table 3 
Stability of enzyme activities 
plasmids 
in ade3 m&l strain $40 carrying different 
Plasmid Carried ADE3 Half life in days of enzymatic 
allele ctivity a(days) 
D C S fl-Gal 
pJS8A ADE3 42 22 >>90 - 
pJS8A-A ADE3(I-333) - 21 - - 
pBJL1 ADE3(1-333)- 
laeZ 6 6 - >>90 
pJS54 ADE3(1-666) 
SER2 2 2 - - 
"The S and fl-Gal activities were stable in the period of experiment (3 
months).'-' indicates no test because of no detectable enzyme activity. 
tained almost half level of the D activity and one-third level of 
the C activity when compared to that with the plasmid pJS8A 
carrying the ADE3 gene. 
Another fusion gene ADE3(1-666)-SER2 has been con- 
structed by fusing the ADE3(1-666) encoding a truncated pro- 
tein to the SER2 gene encoding phosphoserine phosphatase. 
The $40 strain transformed with the multicopy plasmid pJS54 
carrying the constructed ADE3(1-666)-SER2 does not require 
adenine for growth. Enzyme assays how that it retained a low 
level of the D/C activities (Table 2). 
One possible xplanation for the recovery of the D/C activi- 
ties in the $40 strain transformed with the plasmid pBJL1 and 
the D activity in the strain transformed with the plasmid pJS54 
is that the C-terminal portions, fl-galactosidase and phospho- 
serine phosphatase of the fusion protein protects the N-termi- 
nal D/C domain from the proteolysis at the C-terminus by 
extending the length of polypeptide. To investigate this pos- 
sibility, we have compared the stability in vitro among the 
fusion proteins encoded by the ADE3(1-333) lacZ gene and the 
ADE3(1-666) SER2 gene, the truncated protein encoded by the 
ADE3(1-333) gene, and the Ade3 protein. The enzyme stability 
was determined by examining the half life of the enzymatic 
activities in vitro (Table 3). The D/C activities of the fusion 
protein is less stable than those of the Ade3 protein. The C 
activity of the fusion protein is also less stable than that of the 
truncated protein, while the C activity of the truncated protein 
is as stable as that of the Ade3 protein. However, the fl-galac- 
tosidase activity of the fusion protein and the S activity of the 
Ade3 protein were stable for 3 months. These results indicate 
that the retained D/C activities of the fusion protein are not due 
to the protection from proteolysis at the C-terminus by the 
extended length of the polypeptide added. Rather, they suggest 
that the decay of N-terminal D/C domain occurs from the 
N-terminus or middle portion of the domain, and the D/C 
activities of the fusion protein are retained by the contribution 
of the C-terminal end on the enzyme stability in vitro. This 
explanation is supported by the fact that the D/C activities of 
the Ade3 protein is higher and more stable than those of the 
ADE3(I-333)- lacZ fusion protein, although the C-terminal 
portion of the Ade3 protein is 403-amino acids shorter than 
that of the fusion protein. However, at this point, we cannot 
distinguish between the possibilities that: (1) the C-terminal 
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domain of the Ade3 protein protects the activity of the N- 
terminal domain (D) from the presence of an endogenous pro- 
teolytic enzyme, or (2) it is required for stabilizing the active 
conformation of the N-terminal domain. 
These results demonstrate hat the N-terminal D/C domain 
of the yeast cytoplasmic C1-THF synthase requires the C-ter- 
minal S domain for the catalytic activity in vitro, in contrast to 
the fact that both domains of the human C1-THF synthase 
form active enzymes and fold independently in E. coli [14]. The 
ADE3(1-333)-lacZ gene used in this study would be used to 
identify missense mutations on the D/C domain of ADE3 gene, 
which cause the defectived catalytic activity and require ade- 
nine for growth. Such mutations could be contributed toclarify 
the relationship between the catalytic activity of C1-THF syn- 
thase and the purine biosynthesis. 
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